Astrana Health, Inc.
ASTH
$23.18
$0.140.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -84.73% | -63.08% | -43.92% | -28.93% | 39.93% |
| Total Depreciation and Amortization | 51.70% | 34.02% | 59.98% | 57.35% | 46.09% |
| Total Amortization of Deferred Charges | 94.08% | 76.26% | 60.76% | 72.29% | 82.05% |
| Total Other Non-Cash Items | 349.20% | 163.61% | 276.72% | 254.93% | -63.77% |
| Change in Net Operating Assets | 137.74% | 151.70% | -75.60% | -171.99% | -142.71% |
| Cash from Operations | 29.22% | 104.42% | -5.47% | -23.49% | -38.41% |
| Capital Expenditure | 23.76% | 35.16% | 23.60% | 71.85% | 43.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -393.74% | 73.92% | -67.27% | -2,146.01% | -661.30% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 143.40% | 93.64% | 66.08% | -25.00% | -1,199.49% |
| Cash from Investing | -235.06% | 77.24% | -1.00% | -193.63% | -316.92% |
| Total Debt Issued | 146.95% | -8.73% | 20.61% | -39.59% | 9,420.12% |
| Total Debt Repaid | -126.23% | -107.44% | -116.49% | 86.77% | -17,278.27% |
| Issuance of Common Stock | 202.94% | 202.94% | 202.94% | -65.64% | -96.37% |
| Repurchase of Common Stock | -51.18% | -57.00% | -1,268.15% | 52.10% | 53.78% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 89.59% | 89.97% | 91.23% | 99.85% | -1,554.78% |
| Other Financing Activities | -310.01% | -303.78% | -390.26% | -3.72% | -1,877.63% |
| Cash from Financing | 257.39% | -143.17% | -113.16% | 3,850.48% | 6,112.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 55.59% | -54.58% | -225.40% | -182.47% | -17.63% |